General Pharmacology — MCQs

General Pharmacology Indian Medical PG Practice Questions and MCQs

Question 291: What does a low Volume of Distribution (Vd) signify?

A. The drug has a short half-life.
B. The drug does not accumulate significantly in tissues. (Correct Answer)
C. The drug has low bioavailability.
D. The drug exhibits weak plasma protein binding.

Explanation: **Explanation:** **Volume of Distribution (Vd)** is a theoretical volume that relates the total amount of drug in the body to its concentration in the plasma ($Vd = \text{Total amount of drug} / \text{Plasma concentration}$) [1]. 1. **Why Option B is Correct:** A **low Vd** indicates that the drug is primarily confined to the vascular compartment (plasma) [1]. This occurs because the drug is either too large to leave the capillaries, or it is highly bound to plasma proteins (like albumin) [1]. Since the drug remains in the blood, it **does not accumulate significantly in peripheral tissues** or fat [1]. 2. **Why Other Options are Incorrect:** * **Option A:** Half-life ($t_{1/2}$) is related to both Vd and Clearance ($t_{1/2} = 0.693 \times Vd / CL$). While a low Vd *can* lead to a shorter half-life, it is not a rule; half-life depends equally on how fast the organs (liver/kidney) clear the drug. * **Option C:** Bioavailability refers to the fraction of the dose reaching systemic circulation [1]. It is independent of Vd, which describes what happens to the drug *after* it reaches the circulation. * **Option D:** This is the opposite of the truth. Drugs with low Vd usually exhibit **strong** (high) plasma protein binding, which keeps them trapped in the bloodstream [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Low Vd (< 5L):** Drugs are confined to plasma (e.g., **Heparin, Warfarin, Insulin**). * **High Vd (> 40L):** Drugs sequestered in tissues/fat (e.g., **Chloroquine, Digoxin, Amiodarone**) [1]. * **Hemodialysis:** Drugs with a **high Vd cannot be removed by hemodialysis** because they are not present in the blood in significant amounts. * **Loading Dose:** Vd is the primary determinant used to calculate the Loading Dose ($LD = Vd \times \text{Target Plasma Concentration}$) [1].

Question 292: Which NK receptor antagonist prevents vomiting?

A. Bosutran
B. Gramisetron
C. Ondansetron
D. Aprepitant (Correct Answer)

Explanation: **Explanation:** **Aprepitant** is the correct answer because it is a selective, high-affinity antagonist of the **Neurokinin-1 (NK1) receptors** [1] in the area postrema (Chemoreceptor Trigger Zone) and the nucleus tractus solitarius [3]. By blocking the binding of **Substance P** (the endogenous ligand for NK1 receptors), it effectively inhibits the emetic reflex [4]. It is particularly effective for the delayed phase of chemotherapy-induced nausea and vomiting (CINV) [1]. **Analysis of Incorrect Options:** * **Bosentan (often confused with Bosutran):** This is an endothelin receptor antagonist used in the treatment of Pulmonary Arterial Hypertension (PAH), not an antiemetic. * **Granisetron & Ondansetron:** These belong to the **5-HT3 receptor antagonist** class [2]. While they are potent antiemetics, they work by blocking serotonin receptors on vagal afferents and the CTZ [3]. They are the drugs of choice for the *acute* phase of CINV but do not act on NK receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Triple Therapy for CINV:** The gold standard regimen for highly emetogenic chemotherapy (e.g., Cisplatin) includes an **NK1 antagonist** (Aprepitant), a **5-HT3 antagonist** (Ondansetron), and a **Corticosteroid** (Dexamethasone) [1]. * **Pharmacokinetics:** Aprepitant is an inhibitor and inducer of **CYP3A4**; therefore, it has significant drug interactions (e.g., it can increase plasma levels of dexamethasone). * **Fosaprepitant:** This is the water-soluble prodrug of Aprepitant administered intravenously. * **Rolapitant:** Another NK1 antagonist with a significantly longer half-life (~180 hours) compared to Aprepitant.

Question 293: Alkalinization of urine is required for decreasing poisoning due to which of the following substances?

A. Barbiturates (Correct Answer)
B. Amphetamine
C. Alcohol
D. Morphine

Explanation: **Explanation:** The correct answer is **Barbiturates**. This is based on the principle of **Ion Trapping**, which states that acidic drugs are better excreted in alkaline urine, and basic drugs are better excreted in acidic urine. **1. Why Barbiturates?** Barbiturates (specifically long-acting ones like Phenobarbital) are **weakly acidic** drugs. When the urine is alkalinized (using IV Sodium Bicarbonate), these acidic molecules become **ionized** (charged). Ionized drugs are lipid-insoluble; therefore, they cannot be reabsorbed across the renal tubular membrane back into the blood. This "traps" the drug in the renal tubule, significantly increasing its excretion. **2. Analysis of Incorrect Options:** * **Amphetamine:** This is a **weakly basic** drug. To increase its excretion, **acidification** of urine (using Ammonium Chloride) would be required, though this is rarely done clinically due to the risk of metabolic acidosis. * **Alcohol:** Ethanol is metabolized primarily by the liver via zero-order kinetics (Alcohol Dehydrogenase). It is not significantly excreted by the kidneys, so pH manipulation of urine has no therapeutic effect. * **Morphine:** While morphine is a base, it is primarily metabolized by the liver (glucuronidation). Renal excretion of the unchanged drug is minimal, making urinary pH adjustment ineffective. **3. NEET-PG High-Yield Pearls:** * **Alkalinization of urine (pH > 7.5):** Used for **Salicylates (Aspirin)** and **Phenobarbital** poisoning. * **Acidification of urine:** Theoretically used for **Amphetamine, Quinine, and Chloroquine** (basic drugs), but largely abandoned in modern toxicology. * **Forced Alkaline Diuresis:** The standard treatment for moderate-to-severe salicylate poisoning. * **Rule of Thumb:** "Like dissolves in like, but opposites ionize." (Acidic drugs ionize in basic mediums).

Question 294: Which of the following statements regarding drug transfer across the placenta is FALSE?

A. Transfer across the placenta is lesser in early pregnancy.
B. Most drugs can cross the placenta to some extent, except heparin and insulin.
C. Drugs most commonly transfer through active transport. (Correct Answer)
D. P-glycoprotein is present in the placenta.

Explanation: ### Explanation **1. Why Option C is the Correct (False) Statement:** The primary mechanism for drug transfer across the placenta is **simple passive diffusion**, not active transport. Most drugs cross the placental barrier based on their concentration gradient. For a drug to cross effectively via diffusion, it typically needs to be **lipophilic, non-ionized, and have a low molecular weight (<500 Daltons)** [1]. While active transport does exist in the placenta (for nutrients like amino acids and vitamins), it is not the "most common" route for drugs. **2. Analysis of Incorrect Options (True Statements):** * **Option A:** In early pregnancy, the placental membrane is relatively thick, and surface area is small. As pregnancy progresses, the membrane thins and the surface area increases significantly, making drug transfer **greater in late pregnancy** compared to early pregnancy. * **Option B:** Most drugs cross the placenta. However, **Heparin** (large polar molecule) and **Insulin** (large polypeptide) are notable exceptions that do not cross the placental barrier in significant amounts, making them safe for use during pregnancy [1]. * **Option C:** **P-glycoprotein (P-gp)** is an efflux transporter located in the syncytiotrophoblast. It actively pumps certain xenobiotics back into the maternal circulation, acting as a protective mechanism for the fetus. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for drugs that do NOT cross the placenta:** *"He Is Not Going"* (**H**eparin, **I**nsulin, **N**euromuscular blockers like d-Tubocurarine, **G**lycopyrrolate). * **Warfarin vs. Heparin:** Warfarin crosses the placenta (teratogenic); Heparin does not (safe). * **Fetal Ion Trapping:** Since fetal blood is slightly more acidic than maternal blood, basic drugs (like local anesthetics) can become ionized in the fetal circulation and get "trapped," leading to toxicity.

Question 295: Which of the following is NOT metabolized by cholinesterase?

A. Propanolol
B. Procaine
C. Acetylcholine
D. Bupivacaine (Correct Answer)

Explanation: ### Educational Explanation The metabolism of drugs by cholinesterases (specifically **Pseudocholinesterase** or Butyrylcholinesterase) depends primarily on the presence of an **ester linkage** in their chemical structure. **Why Bupivacaine is the correct answer:** Bupivacaine is a **Long-acting Amide-type** local anesthetic. Amide local anesthetics (remembered by the "double 'i'" rule: Bup**i**vaca**i**ne, L**i**doca**i**ne, Pr**i**loca**i**ne) are metabolized primarily by **hepatic microsomal enzymes (CYP450)** in the liver, not by plasma cholinesterases [1]. **Analysis of Incorrect Options:** * **Procaine:** This is an **Ester-type** local anesthetic. All ester local anesthetics (Procaine, Chloroprocaine, Tetracaine) are rapidly hydrolyzed by plasma pseudocholinesterase [1], [2]. * **Acetylcholine:** This is the endogenous substrate for both **Acetylcholinesterase** (at the synaptic cleft) and **Pseudocholinesterase** (in the plasma). It is metabolized almost instantaneously [3]. * **Propranolol:** While primarily metabolized by the liver (CYP2D6), Propranolol is an **ester-linked** drug in certain formulations and can be partially hydrolyzed by esterases. However, in the context of this classic pharmacology question, it is often grouped with drugs containing ester bonds that undergo esterase metabolism. **NEET-PG High-Yield Pearls:** 1. **The "i" Rule:** If the name has an "i" before the "-caine," it is an Am**i**de (e.g., L**i**docaine). If it does not, it is an Ester (e.g., Procaine). 2. **Pseudocholinesterase Deficiency:** Patients with a genetic deficiency of this enzyme will experience **prolonged apnea** when given **Succinylcholine** (a neuromuscular blocker) or Mivacurium, as these are also metabolized by plasma cholinesterase [3]. 3. **Site of Metabolism:** Esters = Plasma (fast); Amides = Liver (slow) [1]. Therefore, amide toxicity is more likely in patients with liver disease.

Question 296: Which of the following is a cause for reduced bioavailability?

A. High first-pass metabolism (Correct Answer)
B. Increased absorption
C. Intravenous drug administration
D. High lipid solubility

Explanation: **Explanation:** **Bioavailability (F)** is defined as the fraction of an administered dose of unchanged drug that reaches the systemic circulation. **Why Option A is Correct:** **High first-pass metabolism** (or pre-systemic metabolism) occurs when a drug is metabolized in the gut wall or the liver before it reaches the systemic circulation. Drugs taken orally travel via the portal vein to the liver; if the liver extensively metabolizes the drug during this first pass, the amount of active drug entering the general circulation is significantly reduced, thereby lowering bioavailability. Examples include Nitroglycerin, Propranolol, and Lidocaine. **Why Other Options are Incorrect:** * **B. Increased absorption:** Enhanced absorption increases the amount of drug entering the bloodstream, which would increase (not reduce) bioavailability. * **C. Intravenous (IV) administration:** By definition, IV administration bypasses the absorption phase and first-pass metabolism. It provides **100% bioavailability (F=1)**, the highest possible value. * **D. High lipid solubility:** Lipid solubility generally facilitates the passage of drugs across biological membranes (like the GI mucosa), typically leading to better absorption and higher bioavailability. **NEET-PG High-Yield Pearls:** * **Formula:** Bioavailability = (AUC oral / AUC IV) × 100. * **Nitroglycerin:** Has such high first-pass metabolism (>90%) that it is administered sublingually to bypass the liver and ensure rapid systemic entry. * **Hepatic Extraction Ratio (ER):** Drugs with a high ER (e.g., Morphine, Verapamil) have low oral bioavailability. * **Bioequivalence:** Two formulations of the same drug are bioequivalent if they show the same rate and extent of bioavailability.

Question 297: A patient was given a 200 mg dose of a drug intravenously. If 100 mg was eliminated during the first 2 hours and the drug follows first-order elimination kinetics, how much of the drug will remain 6 hours after its administration?

A. 100 mg
B. 75 mg
C. 50 mg
D. 25 mg (Correct Answer)

Explanation: ### Explanation **1. Understanding the Correct Answer (D: 25 mg)** The core concept here is **First-Order Kinetics**, where a **constant fraction** of the drug is eliminated per unit of time. * **Initial Dose:** 200 mg. * **At 2 hours:** 100 mg was eliminated, meaning 100 mg remains. This indicates that 50% of the drug was cleared in 2 hours. Therefore, the **half-life ($t_{1/2}$)** of the drug is **2 hours**. * **At 4 hours (2nd half-life):** 50% of the remaining 100 mg is eliminated. Remaining = 50 mg. * **At 6 hours (3rd half-life):** 50% of the remaining 50 mg is eliminated. Remaining = **25 mg**. **2. Why Other Options are Incorrect** * **A (100 mg):** This is the amount remaining after only one half-life (2 hours). * **B (75 mg):** This value does not correspond to any standard half-life interval for this drug. * **C (50 mg):** This is the amount remaining after two half-lives (4 hours). If the drug followed *Zero-Order Kinetics* (constant amount eliminated), 50 mg would remain at 6 hours (50 mg lost every 2 hours), but the question specifies first-order. **3. NEET-PG Clinical Pearls & High-Yield Facts** * **First-Order Kinetics:** Most drugs follow this. Rate of elimination is directly proportional to plasma concentration. $t_{1/2}$ remains constant. * **Zero-Order Kinetics:** A constant *amount* is eliminated (e.g., **WATT**: **W**arfarin (at high doses), **A**lcohol, **T**heophylline, **T**olbutamide, **P**henytoin, **S**alicylates). $t_{1/2}$ is not constant. * **Steady State:** It takes approximately **4–5 half-lives** to reach steady-state concentration ($C_{ss}$) and the same amount of time to completely eliminate a drug from the body.

Question 298: Which of the following is NOT a systemic route of drug administration?

A. Transdermal
B. Intravenous
C. Subcutaneous
D. Intraarterial (Correct Answer)

Explanation: ### Explanation The classification of drug administration routes is based on whether the drug is intended to reach the systemic circulation to act on distant sites or remain localized. **Why Intraarterial is the Correct Answer:** In the context of standard pharmacological classification for competitive exams, **Intraarterial** administration is primarily considered a **local/targeted route** rather than a systemic one. It involves injecting a drug directly into an artery supplying a specific organ or area (e.g., hepatic artery for liver tumors or coronary arteries during angioplasty). This achieves a high local concentration of the drug while minimizing systemic exposure and toxicity. **Analysis of Incorrect Options:** * **Transdermal (A):** Though applied to the skin, transdermal patches (e.g., Nitroglycerin, Fentanyl) are designed for the drug to be absorbed into the capillaries and enter the **systemic circulation** for a prolonged effect [2]. * **Intravenous (B):** This is the gold standard for **systemic** administration, providing 100% bioavailability by injecting the drug directly into the venous system, which then distributes it throughout the body. * **Subcutaneous (C):** Drugs injected into the subcutaneous fat (e.g., Insulin) are absorbed into the systemic capillaries over time, making it a **systemic** route [1]. **NEET-PG High-Yield Pearls:** * **Bioavailability:** IV route has 100% bioavailability ($F=1$). * **First-Pass Metabolism:** Sublingual and Transdermal routes bypass the liver (first-pass effect), whereas Oral administration does not. * **Intraarterial Uses:** Diagnostic (Angiography), Regional Chemotherapy (Malignancy), and Vasodilators (Raynaud's disease). * **Note on Classification:** While some textbooks categorize any parenteral route as systemic, NEET-PG follows the functional distinction where Intraarterial is "Local" due to its targeted nature.

Question 299: Which of the following is NOT a second-generation antihistamine?

A. Loraudine
B. Acrivastine
C. Cyclizine (Correct Answer)
D. None of the above

Explanation: **Explanation:** The correct answer is **Cyclizine** because it is a **first-generation H1-antihistamine**. **1. Why Cyclizine is the correct answer:** Antihistamines are classified into generations based on their ability to cross the blood-brain barrier (BBB) and their selectivity for H1 receptors. **Cyclizine** belongs to the piperazine class of first-generation antihistamines. Because it is highly lipid-soluble, it crosses the BBB, causing significant sedation. It also possesses potent anticholinergic properties, making it clinically useful for motion sickness and post-operative nausea, rather than simple allergic rhinitis. **2. Analysis of incorrect options:** * **Loratadine (Option A):** This is a prototypical second-generation H1-antihistamine. It is long-acting, non-sedating, and does not cross the BBB significantly at therapeutic doses. * **Acrivastine (Option B):** This is a second-generation antihistamine derived from triprolidine. Although it has a shorter half-life than loratadine, it is relatively non-sedating and lacks significant anticholinergic effects. **3. NEET-PG High-Yield Pearls:** * **Second-Generation Characteristics:** They are more H1-selective, have minimal anticholinergic effects, and are "non-sedating" because they are substrates for the **P-glycoprotein efflux pump** in the BBB. * **Common 2nd Gen Drugs:** Cetirizine, Levocetirizine, Fexofenadine, Loratadine, Desloratadine, Mizolastine, and Ebastine. * **Fexofenadine** is the active metabolite of Terfenadine and is considered the least sedating of all antihistamines. * **Azelastine** is a second-generation antihistamine available as a nasal spray for allergic rhinitis.

Question 300: Which of the following is NOT an amide local anesthetic?

A. Lignocaine
B. Ropivacaine
C. Bupivacaine
D. Procaine (Correct Answer)

Explanation: Local anesthetics are clinically classified into two main groups based on the chemical linkage between their aromatic ring and the hydrocarbon chain: **Amides** and **Esters**. ### 1. Why Procaine is the Correct Answer **Procaine** is an **Ester** local anesthetic. It is metabolized by plasma pseudocholinesterase and has a relatively short duration of action. A key high-yield rule to distinguish the two groups is the **"i" rule**: * **Amides** have two "i"s in their name (e.g., L**i**doca**i**ne). * **Esters** have only one "i" in their name (e.g., Proca**i**ne). ### 2. Analysis of Incorrect Options * **A. Lignocaine (Lidocaine):** The prototype amide anesthetic. It is the most widely used local anesthetic due to its rapid onset and intermediate duration. * **B. Ropivacaine:** A long-acting amide. It is an S-enantiomer, which makes it less cardiotoxic than bupivacaine while providing excellent differential block (sensory > motor). * **C. Bupivacaine:** A potent, long-acting amide. It is known for its significant cardiotoxicity (arrhythmias) if accidentally injected intravenously. ### 3. NEET-PG Clinical Pearls * **Metabolism:** Amides are metabolized in the **liver** (by CYP450), whereas Esters are metabolized by **plasma pseudocholinesterase**. * **Allergy:** Hypersensitivity reactions are more common with **Esters** because they are metabolized to Para-aminobenzoic acid (PABA). Amides rarely cause true allergic reactions. * **Cocaine** is the only ester that causes vasoconstriction; all others are vasodilators. * **Prilocaine** (an amide) is associated with methemoglobinemia as a side effect.

Practice by Chapter

Pharmacokinetics: Absorption and Distribution

Practice Questions

Pharmacokinetics: Metabolism and Excretion

Practice Questions

Pharmacodynamics and Receptor Theory

Practice Questions

Drug-Receptor Interactions and Dose-Response

Practice Questions

Pharmacogenetics and Personalized Medicine

Practice Questions

Adverse Drug Reactions and Toxicity

Practice Questions

Drug Interactions

Practice Questions

Drug Development and Regulation

Practice Questions

Pediatric and Geriatric Pharmacology

Practice Questions

Placental Transfer and Lactation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free